Fecal calprotectin as a predictive factor of relapse in patients with ulcerative colitis treated with tacrolimus : A prospective study

Fecal calprotectin as a predictive factor of relapse in patients with ulcerative colitis treated with tacrolimus : A prospective study - Fecal calprotectin as a predictive factor of relapse in patients with ulcerative colitis treated with tacrolimus : A prospective study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014714

Enrollment

Registered

2014-07-30

Start date

2014-07-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

Measurement of fecal calprotectin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with ulcerative colitistreated treated with tacrolimus

Exclusion criteria

Exclusion criteria: The patients who do not agree with the study

Design outcomes

Primary

Measure	Time frame
The recurrence rate of chronic ulcerative colitis	—

Countries

Japan

Contacts

Public ContactTakafumi Yuki

Shimane University Hospital Division of Gastrointestinal Endoscopy

yukitaka@med.shimane-u.ac.jp0853-20-2190

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026